REFERENCES
- Lee JM. Longevity and Life Preservation in Oriental Medicine, Seoul: Kyung Hee University Press, 1996
- Chae H, Lyoo IK, Lee SJ, et al. An alternative way to individualized medicine: Psychological and physical traits of Sasang typology. J Altem Complement Med 2003; 9: 519–528
- Um JY, Joo JC, Kim KY, et al. Angiotensin converting enzyme gene polymorphism and traditional Sasang classification in Koreans with cerebral infarction. Hereditas 2003; 138: 166–171
- Desvergne B, Wahl i W. Peroxisome proliferator-activated recep-tors: Nuclear control of metabolism. Endocr Rev 1999; 20: 649–688
- Gurnell M. PPARgamma and metabolism: Insights from the study of human genetic variants. Clin Endocrinol (Oxt) 2003; 59: 267–277
- Fajas L, Auboeuf D, Raspe E, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 1997; 272: 1879–1889
- Hsueh WA, Bruemmer D. Peroxisome proliferator-activated receptor gamma: Implications for cardiovascular disease. Hypertension 2004; 43: 297–305
- Kawasaki I, Tahara H, Emoto M, et al. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma 2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects. Osaka City Med J 2002; 48: 23–28
- Bluher M, Paschke R. Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance. Exp Clin Endocrinol Diabetes 2003; 111: 85–90
- Pihlajamaki J, Vanhala M, Vanhala P, et al. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood. Obes Res 2004; 12: 187–190
- Ridker PM, Cook NR, Cheng S, et al. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 859–863
- Altshuler D, Hirschhorn JN, Klannemark M, etal. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76–80
- Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002; 51: 2341–2347
- Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 misdense mutation. Biochem Biophys Res Commun 1997; 241: 270–274
- Herrmann SM, Ringel J, Wang JG, et al. Berlin Diabetes Mellitus (BeDiaM) Study. Peroxisome proliferator-activated receptor-gamma 2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002; 51: 2653–2657
- Ostgren CJ, Lindblad U, Melander O, et al. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg hypertension and diabetes project. J Hypertens 2003; 21: 1657–1662
- Joseph KK. Compass of Health: Using the Art of Sasang Medicine to Maximize Your Health, Franklin Lakes, NJ: The Career Press, 2001
- Oh EY, Min KM, Chung JH, et al. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.] Clin Endocrinol Metab 2000; 85: 1801–1804
- Lee BC, Ahn SY, Doo HK, et al. Susceptibility for ischemic stroke is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor- genes, but not the interleukin-1 gene. Neurosci Lett 2004; 357: 33–36
- Kim SH, Koh BH, Song IB. A study on the standardization of QSCC II. J Constitut Med 1996; 8: 187–246
- Koh BH, Kim SH, Park BG, et al. A study on the Sasang constitutional distribution among the people in the United States of America. J Constitut Med 1999; 11: 119–150
- Song YM, Sung J, Davey Smith G, et al. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004; 35: 831–836
- Tai ES, Corella D, Deurenberg-Yap M, etal. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. ] Lipid Res 2004; 45: 674–685
- Lei HH, Chen MH, Yang WS, et al. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. Metabolism 2000; 49: 1267–1270